ARMP
Price:
$7.08
Market Cap:
$259.91M
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of...[Read more]
Industry
Biotechnology
IPO Date
1994-05-20
Stock Exchange
AMEX
Ticker
ARMP
According to Armata Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 162.59%. This represents a change of 347.81% compared to the average of 36.31% of the last 4 quarters.
The mean historical ROE of Armata Pharmaceuticals, Inc. over the last ten years is -61.31%. The current 162.59% ROE has changed -365.20% with respect to the historical average. Over the past ten years (40 quarters), ARMP's ROE was at its highest in in the September 2023 quarter at 251.58%. The ROE was at its lowest in in the December 2016 quarter at -97.71%.
Average
-61.31%
Median
-109.97%
Minimum
-193.75%
Maximum
215.33%
Discovering the peaks and valleys of Armata Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.67%
Maximum Annual ROE = 215.33%
Minimum Annual Increase = -310.45%
Minimum Annual ROE = -193.75%
| Year | ROE | Change |
|---|---|---|
| 2025 | 79.51% | 101.83% |
| 2024 | 39.39% | -81.71% |
| 2023 | 215.33% | -310.45% |
| 2022 | -102.32% | 12.23% |
| 2021 | -91.17% | -22.49% |
| 2020 | -117.63% | -11.88% |
| 2019 | -133.48% | -6.60% |
| 2018 | -142.91% | -13.94% |
| 2017 | -166.06% | -14.29% |
| 2016 | -193.75% | 4.67% |
The current ROE of Armata Pharmaceuticals, Inc. (ARMP) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
111.41%
5-year avg
28.15%
10-year avg
-61.31%
Armata Pharmaceuticals, Inc.’s ROE is less than Sangamo Therapeutics, Inc. (6.69%), less than Insight Molecular Diagnostics Inc. (380.80%), greater than C4 Therapeutics, Inc. (-50.68%), greater than Codexis, Inc. (-68.09%), greater than OmniAb, Inc. (-20.31%), greater than Genfit S.A. (-596.44%), greater than Nuvectis Pharma, Inc. (-147.78%), less than Neonc Technologies Holdings, Inc. (284.28%), greater than SELLAS Life Sciences Group, Inc. (-47.12%), less than Innate Pharma S.A. (593.93%),
| Company | ROE | Market cap |
|---|---|---|
| 6.69% | $70.43M | |
| 380.80% | $146.02M | |
| -50.68% | $343.73M | |
| -68.09% | $233.60M | |
| -20.31% | $278.67M | |
| -596.44% | $445.68M | |
| -147.78% | $366.58M | |
| 284.28% | $105.37M | |
| -47.12% | $1.15B | |
| 593.93% | $169.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Armata Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Armata Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Armata Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Armata Pharmaceuticals, Inc. (ARMP)?
What is the highest ROE for Armata Pharmaceuticals, Inc. (ARMP)?
What is the 3-year average ROE for Armata Pharmaceuticals, Inc. (ARMP)?
What is the 5-year average ROE for Armata Pharmaceuticals, Inc. (ARMP)?
How does the current ROE for Armata Pharmaceuticals, Inc. (ARMP) compare to its historical average?